Schedule 13D ownership disclosure
DICERNA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 253031108
Event date: 2018-11-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,814,589
- Percent of class
- 4.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-057716
- Form type
- SC 13D
- Filer
- Dicerna Pharmaceuticals Inc
- CIK
- CIK 1399529
- Filed
- Nov 07, 2018
- Reporting period
- Nov 02, 2018
- Description
- Schedule 13D beneficial ownership